Portabel Health: Crowned Winner of Flemingsberg Science STARTUP Award 2025

Quickly finding the right personnel is one of the healthcare sector’s major challenges, especially in times of staff shortages and increasing demands for efficiency. Portabel Health offers a modern solution to these problems through a digital platform that makes it easy for care providers to access qualified nurses and healthcare professionals.

Unlike traditional staffing agencies, Portabel Health enables flexible and cost-effective staffing, where the right competence can be matched with the right assignment on short notice. The platform manages the entire process—from matching and scheduling to communication, resulting in reduced administrative burden.

“Winning the Flemingsberg Science Award STARTUP 2025 is proof that we’re on the right path and that our work is being recognized. It gives us even more motivation to continue building a solution the healthcare system truly needs.” — Omar Ahmed, COO and Co-Founder

By combining technology with a deep understanding of healthcare needs, Portabel Health helps ensure high quality of care—even during sudden changes in staffing. The result is a more sustainable staffing solution that strengthens both the work environment and patient care.

“This win opens doors for us to grow faster and continue developing in an environment that fosters innovation. It’s a significant step in our journey and in our mission to create societal value.” — Abdullah Hariss Qurashi, CEO and Founder of Portabel Health

Portabel Health’s innovative work has not gone unnoticed. This year, they are the winners of the Flemingsberg Science STARTUP Award. In addition to the prize of 10,000 SEK, they gain access to coworking spaces in Novum Labs—a creative, knowledge-driven hub for the next generation of tech and healthcare companies, located in the heart of Flemingsberg.

Published On: 23 May 2025
  • Inhalation Sciences Sweden

    In Flemingsberg, we have access to the advanced labs that we need, and it offers the right facilities we need to expand.

  • Mando Group

    Our research and development has been conducted in co-operation with both KI and Karolinska University Hospital here in Flemingsberg. The positive climate on Campus Flemingsberg encourages original ideas and co-operation.

  • NextCell Pharma

    Flemingsberg is entirely the right place for us due to its closeness to co-operation partners and the clinical research at Karolinska University Hospital.

  • Sprint Bioscience

    Flemingsberg offers us the opportunity to grow and provides a good working environment for our employees. Other advantages are the proximity to research at Karolinska Institutet and the clinical research at Karolinska University Hospita